Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Brian Tomlinson, Yan-Hong Li & Paul Chan. (2022) Evaluating gliclazide for the treatment of type 2 diabetes mellitus. Expert Opinion on Pharmacotherapy 23:17, pages 1869-1877.
Read now
Read now
Brian Tomlinson, Nivritti Gajanan Patil, Manson Fok, Paul Chan & Christopher Wai Kei Lam. (2022) The role of sulfonylureas in the treatment of type 2 diabetes. Expert Opinion on Pharmacotherapy 23:3, pages 387-403.
Read now
Read now
Articles from other publishers (4)
Katarzyna Walczewska-Szewc & Wiesław Nowak. (2020) Structural Determinants of Insulin Release: Disordered N-Terminal Tail of Kir6.2 Affects Potassium Channel Dynamics through Interactions with Sulfonylurea Binding Region in a SUR1 Partner. The Journal of Physical Chemistry B 124:29, pages 6198-6211.
Crossref
Crossref
Sean Brennan, Hussein N. RubaiySaba ImanzadehRuth ReidDavid LodwickRobert I. Norman & Richard D. Rainbow. (2020) Kir6.2-D323 and SUR2A-Q1336: an intersubunit interaction pairing for allosteric information transfer in the KATP channel complex. Biochemical Journal 477:3, pages 671-689.
Crossref
Crossref
Kenneth Pak Kin Lee, Jue Chen & Roderick MacKinnon. (2017) Molecular structure of human KATP in complex with ATP and ADP. eLife 6.
Crossref
Crossref
Michael N. Weedon & Peter Light. 2016. The Genetics of Type 2 Diabetes and Related Traits. The Genetics of Type 2 Diabetes and Related Traits
363
377
.